Steve Shiffrin, the Charles Frank Reavis Sr. Professor of Law, Emeritus, a renowned legal scholar widely recognized for his contributions to the field of constitutional law, particularly the First Amendment, died May 29 in Ithaca.
A grant from the non-profit organization VentureWell helped launch a new class that gives senior design students the opportunity to develop and market their ideas. The class – Fiber Science & Apparel Design Futures – is open to seniors in the departments of Fiber Science & Apparel Design and Design + Environmental Analysis.
Terry Tucker, Ph.D. ‘98 earned the 2022 SUNY Chancellor's Award for Excellence in Teaching in recognition of innovative instruction that brought global education to generations of students at Cornell and beyond.
In the 1800s, Americans were targeted with advertisements for what were often considered “cure-all” medicines, presented in colorful trade cards – now part of a Weill Cornell Medicine collection.
Pascal “Toni” Oltenacu, a professor emeritus of animal science who used mathematical modeling to predict disease, longevity and reproduction in dairy cattle, died Dec. 10, 2022 in Gainesville, Florida. He was 84.
Researchers from Weill Cornell Medicine sampled gut bacteria from healthy fecal microbiota transplantation donors and from recipients with ulcerative colitis, identifying the bacterial strains that correlates with effective treatment.
Thanks to a grant from the USDA, horticulture experts in the College of Agriculture and Life Sciences will help design new training programs for workers in controlled environment agriculture.
As water restrictions tighten in Southern California, the Southwest U.S. sees growing evidence of climate change and drought for millions of western residents, according to a Cornell drought expert.
Desirée LeClercq, professor of employment law and an expert on labor provisions in trade agreements, comments on the first U.S.-Mexico Canada Agreement Free Trade Commission meeting.
Weill Cornell Medicine’s Clinical and Translational Science Center has been awarded a two-year, $1.5 million NIH grant to investigate how social and biological factors help determine COVID-19 outcomes in New York City patients.
